Review
The neu (c-erbB-2) oncogene
Affiliations
- PMID: 2565604
Item in Clipboard
Review
The neu (c-erbB-2) oncogene
Semin Oncol.
1989 Apr.
Abstract
The neu gene was first identified in rat tumors that had been induced by the carcinogen ethyl nitrosourea. The human homolog of neu, usually designated c-erbB-2, is located on chromosome 17, q21. It specifies a transmembrane receptor-like phosphoglycoprotein that is closely related to the EGFr (c-erbB-1). The ligand for c-erbB-2 is not known. A significant proportion of adenocarcinomas (especially of the breast, colon, and pancreas) have amplification and/or overexpression of c-erbB-2. The unique qualities associated with the subset of tumors that overexpress c-erbB-2 have not yet been firmly identified.
Similar articles
-
[Proto-oncogene C-erbB-2 and human cancer].Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 1):309-14. Gan To Kagaku Ryoho. 1990. PMID: 1968737 Japanese.
-
[Amplification of the erbb-2 (Her-2/NEU), erbb-1 (HER-1) and c-myc oncogenes is often combined with the deletion of the short arm of chromosome 17 in human carcinoma].Mol Biol (Mosk). 1993 Jul-Aug;27(4):888-94. Mol Biol (Mosk). 1993. PMID: 8103188 Russian.
-
Neu (c-erbB-2), a tumor marker in carcinoma of the female breast.Pathobiology. 1990;58(6):297-303. doi: 10.1159/000163601. Pathobiology. 1990. PMID: 1981830 Review.
-
Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.Mol Cell Biol. 1987 May;7(5):2019-23. doi: 10.1128/mcb.7.5.2019-2023.1987. Mol Cell Biol. 1987. PMID: 3299059 Free PMC article.
-
What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.Pathol Res Pract. 1993 Dec;189(10):1233-52. doi: 10.1016/S0344-0338(11)80853-8. Pathol Res Pract. 1993. PMID: 7910395 Review.
Cited by
-
Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.Virchows Arch A Pathol Anat Histopathol. 1992;420(5):433-40. doi: 10.1007/BF01600515. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1350695
-
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.Oncogene. 2005 Jul 28;24(32):5053-68. doi: 10.1038/sj.onc.1208685. Oncogene. 2005. PMID: 15856015 Free PMC article.
-
Ab locks for improving the selectivity and safety of antibody drugs.J Biomed Sci. 2020 Jun 25;27(1):76. doi: 10.1186/s12929-020-00652-z. J Biomed Sci. 2020. PMID: 32586313 Free PMC article. Review.
-
Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE.Breast Cancer Res. 2000;2(4):311-20. doi: 10.1186/bcr73. Epub 2000 May 24. Breast Cancer Res. 2000. PMID: 11056689 Free PMC article.
-
Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2.Br J Cancer. 2000 Jan;82(1):46-51. doi: 10.1054/bjoc.1999.0875. Br J Cancer. 2000. PMID: 10638965 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous